Nonseminomatous germ cell tumor
Information
- Disease name
- Nonseminomatous germ cell tumor
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03158064 | Active, not recruiting | Phase 2 | Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors | May 15, 2017 | November 2024 |
| NCT05634785 | Recruiting | Phase 2 | CD30 CAR for CD30+ NSGCT | December 9, 2022 | December 2026 |
| NCT06133543 | Recruiting | N/A | Robot-assisted ICG-guided Sentinel Node Biopsy in Testicular Cancer | September 6, 2023 | October 31, 2026 |
| NCT02689219 | Terminated | Phase 2 | Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors | March 9, 2016 | January 23, 2019 |